scholarly article | Q13442814 |
P356 | DOI | 10.1373/CLINCHEM.2010.161174 |
P8608 | Fatcat ID | release_nyci4y5wdjhvrgoelh3xfzbw4a |
P932 | PMC publication ID | 3261234 |
P698 | PubMed publication ID | 21768219 |
P5875 | ResearchGate publication ID | 51501324 |
P50 | author | Andrew N Hoofnagle | Q87223570 |
P2093 | author name string | Frederick G Strathmann | |
Thomas J Laha | |||
P2860 | cites work | Vitamin D, nervous system and aging | Q28254033 |
Examination of structurally selective derivatization of vitamin D(3) analogues by electrospray mass spectrometry | Q31950170 | ||
Determination of carbofuran by on-line immunoaffinity chromatography with coupled-column liquid chromatography/mass spectrometry | Q33484803 | ||
Vitamin D and ageing: neurological issues. | Q33632088 | ||
Vitamin D and chronic kidney disease | Q33885968 | ||
Ion suppression in mass spectrometry | Q34207350 | ||
Enzymes involved in the activation and inactivation of vitamin D. | Q34367819 | ||
Mass spectrometry in the clinical laboratory | Q34441861 | ||
Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry | Q36653540 | ||
Characterization of benzodiazepine "combinatorial" chemical libraries by on-line immunoaffinity extraction, coupled column HPLC-ion spray mass spectrometry-tandem mass spectrometry | Q36840787 | ||
Liquid chromatography tandem-mass spectrometry (LC-MS/MS)--technique and applications in endocrinology | Q36974482 | ||
Development of a standard reference material for vitamin D in serum | Q37238608 | ||
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry | Q37286989 | ||
Evolution of our understanding of vitamin D. | Q37290299 | ||
Vitamin D: physiology and pathophysiology. | Q37442737 | ||
Disorders of phosphate homeostasis and tissue mineralisation | Q37507342 | ||
A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots | Q38422702 | ||
Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet | Q40156885 | ||
1 alpha,25-(OH)2-vitamin D3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro | Q41198656 | ||
Evaluation of triterpene glycoside estrogenic activity using LC/MS and immunoaffinity extraction | Q43769748 | ||
Sensitive analysis of 1alpha,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography-tandem mass spectrometry | Q43837238 | ||
The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice | Q44237386 | ||
Analytical and clinical validation of a radioimmunoassay for the measurement of 1,25 dihydroxy vitamin D. | Q44257065 | ||
1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. | Q46015814 | ||
Relationship between vitamin D, calcium and parathyroid hormone in Cape Town | Q46123617 | ||
Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects | Q46546281 | ||
Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. | Q46784125 | ||
Liquid chromatography-tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: a noninvasive tool for the assessment of vitamin D status | Q46844830 | ||
Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry. | Q53791619 | ||
On-line post-column Diels-Alder derivatization for the determination of vitamin D3 and its metabolites by liquid chromatography/thermospray mass spectrometry | Q56982226 | ||
Performance of Deming regression analysis in case of misspecified analytical error ratio in method comparison studies | Q61643959 | ||
Determination of drugs from urine by on-line immunoaffinity chromatography-high-performance liquid chromatography-mass spectrometry | Q67998743 | ||
Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure | Q70153551 | ||
On-line immunoaffinity extraction-coupled column capillary liquid chromatography/tandem mass spectrometry: trace analysis of LSD analogs and metabolites in human urine | Q71462532 | ||
Quantitative multi-residue determination of beta-agonists in bovine urine using on-line immunoaffinity extraction-coupled column packed capillary liquid chromatography-tandem mass spectrometry | Q73395543 | ||
Selective analogs of 1alpha,25-dihydroxyvitamin D3 for the study of specific functions of Vitamin D | Q79620969 | ||
Evaluation of a 1,25-dihydroxyvitamin D enzyme immunoassay | Q80159884 | ||
Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency | Q83322737 | ||
C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status | Q83832853 | ||
P4510 | describes a project that uses | ggplot2 | Q326489 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vitamin D | Q175621 |
liquid chromatography-tandem mass spectrometry | Q117788892 | ||
P304 | page(s) | 1279-1285 | |
P577 | publication date | 2011-07-18 | |
P1433 | published in | Clinical Chemistry | Q849687 |
P1476 | title | Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry | |
P478 | volume | 57 |
Q36733570 | 1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis |
Q55381074 | 10 years of 25-hydroxyvitamin-D testing by LC-MS/MS-trends in vitamin-D deficiency and sufficiency. |
Q35916458 | 25-Hydroxyvitamin D Can Interfere With a Common Assay for 1,25-Dihydroxyvitamin D in Vitamin D Intoxication |
Q45997484 | A new sensitive LC/MS/MS analysis of vitamin D metabolites using a click derivatization reagent, 2-nitrosopyridine. |
Q53087790 | A novel Cookson-type reagent for enhancing sensitivity and specificity in assessment of infant vitamin D status using liquid chromatography/tandem mass spectrometry. |
Q26798001 | A novel, fully-automated, chemiluminescent assay for the detection of 1,25-dihydroxyvitamin D in biological samples |
Q35762545 | Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers |
Q37065755 | Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry |
Q36442470 | Circulating vitamin D metabolites and kidney disease in type 1 diabetes |
Q37022548 | Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes |
Q35801389 | Comparative evaluation of new Cookson-type reagents for LC/ESI-MS/MS assay of 25-hydroxyvitamin D3 in neonatal blood samples |
Q87897492 | Comparison of the effect of daily versus bolus dose maternal vitamin D3 supplementation on the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio |
Q38610163 | Derivatization methods for LC-MS analysis of endogenous compounds |
Q33452833 | Derivatization methods for quantitative bioanalysis by LC-MS/MS. |
Q33730953 | Development of a sensitive LC/MS/MS method for vitamin D metabolites: 1,25 Dihydroxyvitamin D2&3 measurement using a novel derivatization agent |
Q90237333 | Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease |
Q47808500 | Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD. |
Q38978858 | Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth |
Q33954224 | Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials |
Q36840607 | Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis |
Q57794134 | Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial |
Q88007698 | Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients |
Q40405562 | Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness. |
Q36711992 | Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery |
Q36668070 | Impaired vitamin D metabolism in CKD |
Q34161811 | Inflammation and vitamin D: the infection connection |
Q37361808 | Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study |
Q38171546 | LC-MS/MS in endocrinology: what is the profit of the last 5 years? |
Q89996076 | Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation |
Q35373671 | Nanoparticulate drug delivery platforms for advancing bone infection therapies. |
Q36431285 | Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease |
Q99638643 | Race, Ancestry and Vitamin D Metabolism: The Multi-Ethnic Study of Atherosclerosis |
Q38169758 | Recent trends in the determination of vitamin D. |
Q36210990 | Research resource: whole transcriptome RNA sequencing detects multiple 1α,25-dihydroxyvitamin D(3)-sensitive metabolic pathways in developing zebrafish |
Q57162227 | Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study |
Q35993503 | Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women |
Q45976194 | The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD. |
Q53695740 | The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine. |
Q30524695 | The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease |
Q38058053 | Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories. |
Q40517679 | Vitamin D Deficiency and Metabolism in HIV-Infected and HIV-Uninfected Men in the Multicenter AIDS Cohort Study |
Q99562840 | Vitamin D Metabolism and Profiling in Veterinary Species |
Q40102586 | Vitamin D Status and Kidney Function Decline in HIV-Infected Men: A Longitudinal Study in the Multicenter AIDS Cohort Study |
Q39162712 | Vitamin D and Cardiovascular Disease: Can Novel Measures of Vitamin D Status Improve Risk Prediction and Address the Vitamin D Racial Paradox? |
Q90531754 | Vitamin D and endocrine disorders: routine laboratory diagnostic implications |
Q38094123 | Vitamin D and metabolites measurement by tandem mass spectrometry |
Q38073649 | Vitamin D assays: past and present debates, difficulties, and developments |
Q52726138 | Vitamin D status and immune function reconstitution in HIV-infected men initiating therapy. |
Q44105008 | Vitamin D: an essential component for skeletal health |